Europe Leukapheresis Market
The Europe Leukapheresis Market size was valued at US$ 22.55 Mn in 2021 and is projected to reach US$ 39.26 Mn by 2028, growing at a CAGR of 8.2% during 2021 - 2028.
Report Coverage
- Product Type: Leukapheresis Devices, Leukapheresis Disposables
- Application: Research Applications, Therapeutic Applications
- End User: Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Transfusion Centers
US$ 22.55 Mn
Market size in 2021
US$ 39.26 Mn
Market Size by 2028
8.2%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Leukapheresis Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Leukapheresis Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Leukapheresis Market Regional Analysis
6.2 Europe Leukapheresis Market Revenue 2019-2028 (US$ Million)
6.3 Europe Leukapheresis Market Forecast Analysis
7. Europe Leukapheresis Market Analysis – by Product Type
7.1 Leukapheresis Devices
- 7.1.1 Overview
- 7.1.2 Leukapheresis Devices: Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Leukapheresis Disposables
- 7.2.1 Overview
- 7.2.2 Leukapheresis Disposables: Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe Leukapheresis Market Analysis – by Application
8.1 Research Applications
- 8.1.1 Overview
- 8.1.2 Research Applications: Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Therapeutic Applications
- 8.2.1 Overview
- 8.2.2 Therapeutic Applications: Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe Leukapheresis Market Analysis – by End User
9.1 Blood Component Providers and Blood Centers
- 9.1.1 Overview
- 9.1.2 Blood Component Providers and Blood Centers: Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Academic and Research Institutes
- 9.2.1 Overview
- 9.2.2 Academic and Research Institutes: Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Pharmaceutical and Biotechnology Companies
- 9.3.1 Overview
- 9.3.2 Pharmaceutical and Biotechnology Companies: Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Hospitals and Transfusion Centers
- 9.4.1 Overview
- 9.4.2 Hospitals and Transfusion Centers : Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Europe Leukapheresis Market – Europe Analysis
10.1 Overview
10.2 Europe- 10.2.1 Europe Leukapheresis Market Breakdown, by Key Country, 2022 and 2028 (%)
- 10.2.1.1 Europe Leukapheresis Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 UK: Europe Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 UK: Europe Leukapheresis Market Breakdown, by Product Type
- 10.2.1.1.2 UK: Europe Leukapheresis Market Breakdown, by Application
- 10.2.1.1.3 UK: Europe Leukapheresis Market Breakdown, by End User
- 10.2.1.2 Germany: Europe Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Germany: Europe Leukapheresis Market Breakdown, by Product Type
- 10.2.1.2.2 Germany: Europe Leukapheresis Market Breakdown, by Application
- 10.2.1.2.3 Germany: Europe Leukapheresis Market Breakdown, by End User
- 10.2.1.3 France: Europe Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 France: Europe Leukapheresis Market Breakdown, by Product Type
- 10.2.1.3.2 France: Europe Leukapheresis Market Breakdown, by Application
- 10.2.1.3.3 France: Europe Leukapheresis Market Breakdown, by End User
- 10.2.1.4 Russia: Europe Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Russia: Europe Leukapheresis Market Breakdown, by Product Type
- 10.2.1.4.2 Russia: Europe Leukapheresis Market Breakdown, by Application
- 10.2.1.4.3 Russia: Europe Leukapheresis Market Breakdown, by End User
- 10.2.1.5 Italy: Europe Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Italy: Europe Leukapheresis Market Breakdown, by Product Type
- 10.2.1.5.2 Italy: Europe Leukapheresis Market Breakdown, by Application
- 10.2.1.5.3 Italy: Europe Leukapheresis Market Breakdown, by End User
- 10.2.1.6 Rest of Europe: Europe Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Leukapheresis Market Breakdown, by Product Type
- 10.2.1.6.2 Rest of Europe: Europe Leukapheresis Market Breakdown, by Application
- 10.2.1.6.3 Rest of Europe: Europe Leukapheresis Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Asahi Kasei Corporation
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Fresenius SE & Co. KGaA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Haemonetics Corporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Terumo Corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 STEMCELL Technologies Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 HemaCare
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Macopharma
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 AllCells
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 STEMEXPRESS
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 BioIVT
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
